Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

NAAS Rating: 5.03, Impact Factor: RJIF 5.98 | Free Publication Certificate
updates
NAAS Rating: 5.03 new
Vol. 7, Issue 10 (2018)

Prescribing pattern of anti-hypertensive drugs by general practitioners in a semi urban area in South India

Author(s):
Dr. M Gangadevi MD and Dr. S Jeyaponmari MD
Abstract:
Background: Hypertension is one of the major chronic diseases with high mortality and morbidity today. The monitoring of trends in hypertension treatment and control can provide an important insight into the effectiveness of primary prevention efforts for cardiovascular disease.
Objective: To analyze the prescribing pattern of anti-hypertensive drugs in a semi urban area by general practitioners.
Methodology: This is an observational study wherein patients suffering from hypertension attending general practitioners in a semi urban area were analyzed. Totally 200 prescriptions were collected and demographic details such as name, age, gender were noted. The prescription data obtained as per proforma was evaluated as per JNC VIII guidelines.
Results: 200 patients were included in the study out of which 57% were females and 43% were males. Mean number of antihypertensive drugs prescribed was 1.58. Most of the patients (54%) were treated with a single antihypertensive drug. Of the patients on combination therapy, 34.5% (69) and 11.5% (23) were on two and three drugs respectively. The use of calcium channel blockers was predominant in monotherapy as well as 2 or 3 drug regimens.
Conclusion: Our study shows that calcium channel blockers were the drugs of choice for hypertensive patients as a single drug therapy and overall utilization and the results were only partly consistent with the JNC VIII guidelines for the treatment of hypertension.
Pages: 404-407  |  187 Views  2 Downloads
How to cite this article:
Dr. M Gangadevi MD, Dr. S Jeyaponmari MD. Prescribing pattern of anti-hypertensive drugs by general practitioners in a semi urban area in South India. Pharma Innovation 2018;7(10):404-407.
The Pharma Innovation Journal